Cargando...
A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection
BACKGROUND: Sorafenib was reported as a useful adjuvant treatment in patients with hepatocellular carcinoma who underwent surgical resection. However, its therapeutic value remains controversial. This meta-analysis examined the available data regarding the efficacy and safety of sorafenib in patient...
Guardado en:
| Publicado en: | World J Surg Oncol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8194151/ https://ncbi.nlm.nih.gov/pubmed/34112190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-021-02280-9 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|